Here is the link.
https://www.practiceupdate.com/c/173221/2/2/?elsca1=emc_enews_daily-digest&elsca2=email&elsca3=practiceupdate_cardio&elsca4=cardiology&elsca5=newsletter&rid=MzEwODYyNjA4MjA0S0&lid=20845073
Here is an excerpt.
Hypertension remains a common and undertreated
cardiovascular risk factor throughout the world. The recommended target for the
treatment of high blood pressure (BP) has long been a systolic BP of less
than 140 mm Hg. The SPRINT trial1 did show that targeting a
systolic BP of less than 120 mm Hg was better than 140 mm Hg in patients at
high cardiovascular risk but without diabetes or stroke. The ESPRIT trial2 has
now validated and extended the SPRINT findings to include patients with
diabetes or stroke.
No comments:
Post a Comment